F.L. Putnam Investment Management’s Transmedics TMDX Stock Holding History

F.L. Putnam Investment Management’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$76.7K	Buy	+1,155	New	+$97.8K	﹤0.01%	647

Other funds holding TMDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

ZCI

Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

F.L. Putnam Investment Management's TMDX Position: Q2 2026 in Review

F.L. Putnam Investment Management opened a new position in Transmedics (TMDX) in Q2 2026: 1,155 shares worth $76.7K. The stake represents ﹤0.01% of the portfolio and ranks #647 among its holdings.

177 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

F.L. Putnam Investment Management held 1,155 shares of Transmedics worth $76.7K as of Q2 2026.
Transmedics was a new F.L. Putnam Investment Management position in Q2 2026.
Transmedics made up ﹤0.01% of F.L. Putnam Investment Management's portfolio in Q2 2026, its #647 holding.
177 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on F.L. Putnam Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.